Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 7079487, 11 pages
http://dx.doi.org/10.1155/2016/7079487
Research Article

Salvianolic Acid B Prevents Iodinated Contrast Media-Induced Acute Renal Injury in Rats via the PI3K/Akt/Nrf2 Pathway

1Division of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Division of Nephrology, The Affiliated Changzhou No. 2 Hospital of Nanjing Medical College, Changzhou, Jiangsu 213003, China
3Shanghai Institute of Kidney and Dialysis, Shanghai 200032, China

Received 14 December 2015; Revised 22 February 2016; Accepted 30 March 2016

Academic Editor: Noriko Noguchi

Copyright © 2016 Liu Tongqiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Crimi, S. Leonardi, F. Costa et al., “Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial,” Catheterization and Cardiovascular Interventions, vol. 86, no. 1, pp. E19–E27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Aguiar-Souto, G. Ferrante, F. Del Furia, P. Barlis, R. Khurana, and C. Di Mario, “Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions,” International Journal of Cardiology, vol. 139, no. 1, pp. 68–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Abe, T. Morimoto, M. Akao et al., “Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention,” The American Journal of Cardiology, vol. 114, no. 3, pp. 362–368, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Jorgensen, “Contrast-induced nephropathy: pathophysiology and preventive strategies,” Critical Care Nurse, vol. 33, no. 1, pp. 37–46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Golshahi, H. Nasri, and M. Gharipour, “Contrast-induced nephropathy; a literature review,” Journal of Nephropathology, vol. 3, no. 2, pp. 51–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kongkham, S. Sriwong, and A. Tasanarong, “Protective effect of alpha tocopherol on contrast-induced nephropathy in rats,” Nefrologia, vol. 33, no. 1, pp. 116–123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kurtoglu, S. Durmaz, C. Akgullu et al., “Ozone preconditioning attenuates contrast-induced nephropathy in rats,” Journal of Surgical Research, vol. 195, no. 2, pp. 604–611, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. X.-B. Li, W. Wang, G.-J. Zhou, Y. Li, X.-M. Xie, and T.-S. Zhou, “Production of salvianolic acid B in roots of Salvia miltiorrhiza (Danshen) during the post-harvest drying process,” Molecules, vol. 17, no. 3, pp. 2388–2407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Zhou, X.-D. Qu, Z.-Y. Li et al., “Salvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease models,” PLoS ONE, vol. 9, no. 7, Article ID e101668, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-Y. Gao, G.-Y. Li, M.-M. Lou, X.-Y. Li, X.-Y. Wei, and J.-H. Wang, “Hepatoprotective effect of Matrine salvianolic acid bsalt on carbon tetrachloride-induced hepatic fibrosis,” Journal of Inflammation, vol. 9, article 16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-L. Liu, L.-X. Xie, M. Li, S. S. K. Durairajan, S. Goto, and J.-D. Huang, “Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling,” PLoS ONE, vol. 2, no. 12, Article ID e1321, 8 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Lin, X. Zhai, G. Wang et al., “Salvianolic acid B protects against acetaminophen hepatotoxicity by inducing Nrf2 and phase II detoxification gene expression via activation of the PI3K and PKC signaling pathways,” Journal of Pharmacological Sciences, vol. 127, no. 2, pp. 203–210, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Ma, Y.-L. Zhao, Y. Zhu et al., “Paeonia lactiflora Pall. protects against ANIT-induced cholestasis by activating Nrf2 via PI3K/Akt signaling pathway,” Drug Design, Development and Therapy, vol. 9, pp. 5061–5074, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-Q. Liu, W.-L. Luo, X. Tan et al., “A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 427560, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Liu, Y. Fang, S. Liu et al., “Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β,” Free Radical Biology and Medicine, vol. 81, pp. 170–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Dwivedi, N. Rajasekar, K. Hanif, C. Nath, and R. Shukla, “Sulforaphane ameliorates okadaic acid-induced memory impairment in rats by activating the Nrf2/HO-1 antioxidant pathway,” Molecular Neurobiology, pp. 1–14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Chen, J. Liu, and S.-Y. Chen, “Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response,” British Journal of Pharmacology, vol. 169, no. 2, pp. 437–448, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Xu, A. Zhong, X. Bu et al., “Salvianolic acid B inhibits platelets-mediated inflammatory response in vascular endothelial cells,” Thrombosis Research, vol. 135, no. 1, pp. 137–145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Wang, X. J. Xiong, and B. Feng, “Cardiovascular effects of salvianolic acid B,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 247948, 16 pages, 2013. View at Publisher · View at Google Scholar
  20. Y. Tang, A. Jacobi, C. Vater, X. Zou, and M. Stiehler, “Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways,” Biochemical Pharmacology, vol. 90, no. 1, pp. 34–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Zhang, T. Kang, Y. Xia et al., “Effects of salvianolic acid B on survival, self-renewal and neuronal differentiation of bone marrow derived neural stem cells,” European Journal of Pharmacology, vol. 697, no. 1–3, pp. 32–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Zhuang, Y. Zhang, G. Cui et al., “Direct stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid B,” PLoS ONE, vol. 7, no. 4, Article ID e35636, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-Y. Tao, Q.-L. Wang, L. Shen, W.-W. Fu, and C.-H. Liu, “Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro,” Experimental Biology and Medicine, vol. 238, no. 11, pp. 1284–1296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Wang, X.-Y. Yu, Z.-Y. Guo, Y.-J. Wang, Y. Wu, and Y.-F. Yuan, “Inhibitory effects of salvianolic acid B on CCl4-induced hepatic fibrosis through regulating NF-κB/IκBα signaling,” Journal of Ethnopharmacology, vol. 144, no. 3, pp. 592–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Q.-L. Wang, Y.-Y. Tao, J.-L. Yuan, L. Shen, and C.-H. Liu, “Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro,” BMC Cell Biology, vol. 11, article 31, 16 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Ferrari and C. F. Andrade, “Oxidative stress and lung ischemia-reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 590987, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Hadadha, A. Vakili, and A. R. Bandegi, “Effect of the inhibition of hydrogen sulfide synthesis on ischemic injury and oxidative stress biomarkers in a transient model of focal cerebral ischemia in rats,” Journal of Stroke and Cerebrovascular Diseases, vol. 24, no. 12, pp. 2676–2684, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Rashikh, K. K. Pillai, S. J. Ahmad, M. Akhtar, and A. K. Najmi, “Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 14, no. 1, pp. 14–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. N. H. Urrunaga, R. N. Jadeja, V. Rachakonda et al., “M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury,” Free Radical Biology & Medicine, vol. 78, pp. 66–81, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Tahmasbpour, S. Reza Emami, M. Ghanei, and Y. Panahi, “Role of oxidative stress in sulfur mustard-induced pulmonary injury and antioxidant protection,” Inhalation Toxicology, vol. 27, no. 13, pp. 659–672, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Šochman, J. H. Peregrin, M. Bürgelová, L. Kopkan, H. J. Kramer, and L. Červenka, “N-acetylcysteine attenuates iodine contrast agent-induced nephropathy in 5/6-nephrectomized rats,” Kidney and Blood Pressure Research, vol. 33, no. 2, pp. 149–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Koc, K. Ozdemir, M. G. Kaya et al., “Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS—a multicenter prospective controlled trial,” International Journal of Cardiology, vol. 155, no. 3, pp. 418–423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Tropeano, M. Leoncini, A. Toso et al., “Impact of rosuvastatin in contrast-induced acute kidney injury in the elderly: post Hoc analysis of the PRATO-ACS trial,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 21, no. 2, pp. 159–166, 2016. View at Publisher · View at Google Scholar
  34. B. Qiao, J. Deng, Y. Li, X. Wang, and Y. Han, “Rosuvastatin attenuated contrast-induced nephropathy in diabetes patients with renal dysfunction,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 2, pp. 2342–2349, 2015. View at Google Scholar · View at Scopus
  35. A. Tasanarong, A. Vohakiat, P. Hutayanon, and D. Piyayotai, “New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures,” Nephrology Dialysis Transplantation, vol. 28, no. 2, pp. 337–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. U. Sadat, A. Usman, J. H. Gillard, and J. R. Boyle, “Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials,” Journal of the American College of Cardiology, vol. 62, no. 23, pp. 2167–2175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Tasanarong, S. Kongkham, and A. Itharat, “Antioxidant effect of Phyllanthus emblica extract prevents contrast-induced acute kidney injury,” BMC Complementary and Alternative Medicine, vol. 14, article 138, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Nasri, A. Ahmadi, A. Baradaran et al., “A biochemical study on ameliorative effect of green tea (Camellia sinensis) extract against contrast media induced acute kidney injury.,” Journal of Renal Injury Prevention, vol. 3, no. 2, pp. 47–49, 2014. View at Publisher · View at Google Scholar
  39. W. Cao, X.-W. Guo, H.-Z. Zheng, D.-P. Li, G.-B. Jia, and J. Wang, “Current progress of research on pharmacologic actions of salvianolic acid B,” Chinese Journal of Integrative Medicine, vol. 18, no. 4, pp. 316–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Wang, G.-B. Sun, X. Sun et al., “Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway,” Toxicology Letters, vol. 216, no. 2-3, pp. 100–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Xu, H. Li, X. Hou et al., “Punicalagin induces Nrf2/HO-1 expression via upregulation of PI3K/AKT pathway and inhibits LPS-induced oxidative stress in RAW264.7 macrophages,” Mediators of Inflammation, vol. 2015, Article ID 380218, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Naziroglu, N. Yoldaş, E. N. Uzgur, and M. Kayan, “Role of contrast media on oxidative stress, Ca2+ signaling and apoptosis in kidney,” The Journal of Membrane Biology, vol. 246, no. 2, pp. 91–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Pisani, E. Riccio, M. Andreucci et al., “Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy,” BioMed Research International, vol. 2013, Article ID 868321, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Shinkai, D. Sumi, I. Fukami, T. Ishii, and Y. Kumagai, “Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes,” FEBS Letters, vol. 580, no. 7, pp. 1771–1774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. W. Zagorski, A. E. Turley, H. E. Dover, K. R. VanDenBerg, J. R. Compton, and C. E. Rockwell, “The Nrf2 activator, tBHQ, differentially affects early events following stimulation of Jurkat cells,” Toxicological Sciences, vol. 136, no. 1, pp. 63–71, 2013. View at Publisher · View at Google Scholar
  46. T. G. Son, S. Camandola, T. V. Arumugam et al., “Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia,” Journal of Neurochemistry, vol. 112, no. 5, pp. 1316–1326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Nakagami, E. Hatano, T. Inoue, K. Yoshida, M. Kondo, and H. Terasaki, “Cytoprotective effects of a novel Nrf2 activator, RS9, in rhodopsin Pro347leu rabbits,” Current Eye Research, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. H.-H. Chen, T.-C. Wang, Y.-C. Lee et al., “Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway,” Chemical Research in Toxicology, vol. 28, no. 9, pp. 1681–1692, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. M. D. Merrell, J. P. Jackson, L. M. Augustine et al., “The Nrf2 activator oltipraz also activates the constitutive androstane receptor,” Drug Metabolism and Disposition, vol. 36, no. 8, pp. 1716–1721, 2008. View at Publisher · View at Google Scholar · View at Scopus